Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

2yrs ago Cannabis greenmarketreport Views: 270

-

Damning testimony continues in the MedMen (OTC: MMNFF) trial with former Chief Financial Officer James Parker. Law360 reported that additional MedMen former employees seemed to support the allegations made by Parker with regards to illegally moving cannabis across state lines and using toxic language. Parker claims he resigned over fears of committing illegal acts and the hostile work environment. MedMen argues that Parker left on his own and broke his employment contract. Parker is asking for millions in pay and stock that he feels is owed to him.

Crossing The Line

The most serious charges revolve around the accusations that MedMen moved cannabis from California to a cultivation facility in Nevada. Crossing state lines is illegal even if a state has legalized cannabis. According to Law360, Barry Fischetto, the company’s former chief operating officer said that he told Andrew Modlin, MedMen’s co-founder, and former president, that he “wasn’t going to jail for him” when asked about potentially moving cannabis plants to Nevada, and that Modlin was not happy about his answer.

Toxic Language

The report also stated that Fischetto “told the jury he was certain MenMen’s co-founder and former CEO Adam Bierman called Parker a “pussy” when Parker raised concerns about the company potentially breaking the law by accepting credit card payments at its cannabis dispensaries.”

“I was standing right next to him,” Fischetto said. He also said he heard Modlin use the word “retard” at least “a thousand times.”

Scott Lloyd, a former recruiting director also supported Parker’s claim of offensive language by the MedMen leaders. The report read, “Lloyd told the jury about an incident he said occurred in the lobby of a San Diego hotel during an executive retreat, which was similar to Parker’s testimony. According to Lloyd, Bierman yelled in the lobby for someone to tell a gay employee to stop “fisting” his boyfriend and get down to the lobby.”

Replacement Fears

One of the reasons why Parker began to believe he was going to be fired by MedMen was that he found a $50,000 invoice for an executive search firm called Leadership Capital Partners. Parker had testified already that the invoice was purposely mislabeled so that he wouldn’t notice it. Law36 reported that on Tuesday, William Tsai of Leadership Capital Partners testified “that he was hired by MedMen in September 2018 to find a new CEO and to creatively label his invoice to hide its true nature. Under cross-examination, he said that during an interview Bierman told a recruit the job’s title was “fungible” and might not be for the CFO.”

There was also a discussion regarding the valuation of the shares that Parker is claiming to be owed. Parker thinks he should receive $7.39 million in severance pay and $17.5 million in stock.

MedMen will release its financial results for the first quarter fiscal 2022 ended September 25, 2021, after market close on Tuesday, November 9, 2021.

 

 

 

 

MedMen’s Ex-CFO Is Backed Up In Court By Others on Green Market Report.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.